Maria Guijarro, PhD
Assistant Scientist
Publications
2023
Corrigendum: Targeting thymidylate synthase enhances the chemosensitivity of triple-negative breast cancer towards 5-FU-based combinatorial therapy.
Frontiers in oncology.
13
[DOI] 10.3389/fonc.2023.1302413.
[PMID] 38162481.
2023
First-in-class multifunctional TYMS nonclassical antifolate inhibitor with potent in vivo activity that prolongs survival.
JCI insight.
8(10)
[DOI] 10.1172/jci.insight.158798.
[PMID] 37097751.
2023
MiR-130b modulates the invasive, migratory, and metastatic behavior of leiomyosarcoma.
PloS one.
18(1)
[DOI] 10.1371/journal.pone.0278844.
[PMID] 36701370.
2023
TYMS promotes genomic instability and tumor progression in Ink4a/Arf null background.
Oncogene.
42(23):1926-1939
[DOI] 10.1038/s41388-023-02694-7.
[PMID] 37106126.
2022
Thymidylate synthase accelerates Men1-mediated pancreatic tumor progression and reduces survival.
JCI insight.
7(19)
[DOI] 10.1172/jci.insight.147417.
[PMID] 36048542.
2021
Targeting Thymidylate Synthase Enhances the Chemosensitivity of Triple-Negative Breast Cancer Towards 5-FU-Based Combinatorial Therapy.
Frontiers in oncology.
11
[DOI] 10.3389/fonc.2021.656804.
[PMID] 34336653.
2020
Tsc1 Regulates the Proliferation Capacity of Bone-Marrow Derived Mesenchymal Stem Cells.
Cells.
9(9)
[DOI] 10.3390/cells9092072.
[PMID] 32927859.
2019
Oncolytic virotherapy for small-cell lung cancer induces immune infiltration and prolongs survival.
The Journal of clinical investigation.
129(6):2279-2292
[DOI] 10.1172/JCI121323.
[PMID] 31033480.
2018
Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models.
Carcinogenesis.
39(8):1068-1078
[DOI] 10.1093/carcin/bgy073.
[PMID] 29846515.
2018
Lentiviral-based reporter constructs for profiling chondrogenic activity in primary equine cell populations.
European cells & materials.
36:156-170
[DOI] 10.22203/eCM.v036a12.
[PMID] 30311630.
2017
Genome-Wide miRNA Screening for Genes Bypassing Oncogene-Induced Senescence.
Methods in molecular biology (Clifton, N.J.).
1534:53-68
[PMID] 27812867.
2015
Limited miR-17-92 overexpression drives hematologic malignancies.
Leukemia research.
39(3):335-41
[DOI] 10.1016/j.leukres.2014.12.002.
[PMID] 25597017.
2014
Animal models in osteosarcoma.
Frontiers in oncology.
4
[DOI] 10.3389/fonc.2014.00189.
[PMID] 25101245.
2014
Corrigendum: Animal models in osteosarcoma.
Frontiers in genetics.
5
[DOI] 10.3389/fgene.2014.00475.
[PMID] 25641581.
2014
Osteosarcoma: mouse models, cell of origin and cancer stem cell.
Postdoc journal : a journal of postdoctoral research and postdoctoral affairs.
2(2):19-30
[PMID] 27617267.
2013
Cardiovascular dysregulation of miR-17-92 causes a lethal hypertrophic cardiomyopathy and arrhythmogenesis.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
27(4):1460-7
[DOI] 10.1096/fj.12-221994.
[PMID] 23271053.
2013
Dual Pten/Tp53 suppression promotes sarcoma progression by activating Notch signaling.
The American journal of pathology.
182(6):2015-27
[DOI] 10.1016/j.ajpath.2013.02.035.
[PMID] 23708211.
2013
FBH1 protects melanocytes from transformation and is deregulated in melanomas.
Cell cycle (Georgetown, Tex.).
12(7):1128-32
[DOI] 10.4161/cc.24165.
[PMID] 23466708.
2013
Inactivation of Patched1 in mice leads to development of gastrointestinal stromal-like tumors that express Pdgfrα but not kit.
Gastroenterology.
144(1):134-144.e6
[DOI] 10.1053/j.gastro.2012.09.061.
[PMID] 23041331.
2012
p38α limits the contribution of MAP17 to cancer progression in breast tumors.
Oncogene.
31(41):4447-59
[DOI] 10.1038/onc.2011.619.
[PMID] 22266858.
2010
A differentiation-based microRNA signature identifies leiomyosarcoma as a mesenchymal stem cell-related malignancy.
The American journal of pathology.
177(2):908-17
[DOI] 10.2353/ajpath.2010.091150.
[PMID] 20558575.
2008
Cellular senescence bypass screen identifies new putative tumor suppressor genes.
Oncogene.
27(14):1961-70
[PMID] 17968325.
2008
Chemokine signaling via the CXCR2 receptor reinforces senescence.
Cell.
133(6):1006-18
[DOI] 10.1016/j.cell.2008.03.038.
[PMID] 18555777.
2008
PPP1CA contributes to the senescence program induced by oncogenic Ras.
Carcinogenesis.
29(3):491-9
[DOI] 10.1093/carcin/bgm246.
[PMID] 18204081.
2007
Large scale genetic screen identifies MAP17 as protein bypassing TNF-induced growth arrest.
Journal of cellular biochemistry.
101(1):112-21
[PMID] 17230460.
2007
MAP17 enhances the malignant behavior of tumor cells through ROS increase.
Carcinogenesis.
28(10):2096-104
[PMID] 17548903.
2007
MAP17 inhibits Myc-induced apoptosis through PI3K/AKT pathway activation.
Carcinogenesis.
28(12):2443-50
[PMID] 17675338.
2007
MAP17 overexpression is a common characteristic of carcinomas.
Carcinogenesis.
28(8):1646-52
[PMID] 17426052.
Contact Details
Phones:
- Business:
- (352) 273-9156
Emails:
- Business:
- guijam@ufl.edu
Addresses:
- Business Mailing:
-
PO Box 103633
GAINESVILLE FL 32610 - Business Street:
-
2033 MOWRY RD # CGRC365
GAINESVILLE FL 326103010